Lestaurtinib
- Product Name
- Lestaurtinib
- CAS No.
- 111358-88-4
- Chemical Name
- Lestaurtinib
- Synonyms
- SP 924;SPM-924;CS-1165;CEP 701;KT 5555;ritatinib;A 154475.0;lestaurtinib;KT-5555 hydrate;CEP-701 hydrate
- CBNumber
- CB3506750
- Molecular Formula
- C26H21N3O4
- Formula Weight
- 439.47
- MOL File
- 111358-88-4.mol
Lestaurtinib Property
- Melting point:
- 215-220°C
- Boiling point:
- 723.0±60.0 °C(Predicted)
- Density
- 1.70±0.1 g/cm3(Predicted)
- storage temp.
- Desiccate at -20°C
- solubility
- DMSO: >10mg/mL
- form
- white powder
- pka
- 13.37±0.40(Predicted)
- color
- White or off-white
- Stability:
- Photosensitive
- InChIKey
- LPOQWFBZBJTLEO-GMEYHWBASA-N
- SMILES
- O.C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35
Safety
- WGK Germany
- 3
- HS Code
- 2934999090
- Storage Class
- 11 - Combustible Solids
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P271Use only outdoors or in a well-ventilated area.
P280Wear protective gloves/protective clothing/eye protection/face protection.
N-Bromosuccinimide Price
- Product number
- C7869
- Product name
- CEP-701 hydrate
- Purity
- ≥98% (HPLC)
- Packaging
- 1mg
- Price
- $192
- Updated
- 2025/07/31
- Product number
- C7869
- Product name
- CEP-701 hydrate
- Purity
- ≥98% (HPLC)
- Packaging
- 5mg
- Price
- $747
- Updated
- 2025/07/31
- Product number
- 12094
- Product name
- Lestaurtinib
- Purity
- ≥98%
- Packaging
- 500μg
- Price
- $44
- Updated
- 2024/03/01
- Product number
- 12094
- Product name
- Lestaurtinib
- Purity
- ≥98%
- Packaging
- 1mg
- Price
- $70
- Updated
- 2024/03/01
- Product number
- 12094
- Product name
- Lestaurtinib
- Purity
- ≥98%
- Packaging
- 5mg
- Price
- $151
- Updated
- 2024/03/01
Lestaurtinib Chemical Properties,Usage,Production
Description
Lestaurtinib (111358-88-4) is a potent and selective FLT3 inhibitor (IC50= 2 nM).1,2Inhibits RET and RET phosphorylation in medullary thyroid carcinoma cells.3Suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.4Potent Trk inhibitor.5Cell permeable.
Chemical Properties
Lestaurtinib is Off-White Solid
Uses
Lestaurtinib is used for the treatment of pancreatic cancer and acute myelogenous leukaemia (AML)
Uses
CEP-701 hydrate has been used as a tyrosine kinase inhibitor:
- to study its effects on early growth response protein (EGR) genes and nerve growth factor (NGF) stimulation in human epithelial cells
- as a supplement in reservoir solution for co-crystallization studies with human receptor-interactingprotein kinase4 (RIPK4)
- as an FMS-like tyrosine kinase 3 (FLT3) inhibitor-gold nanoparticle conjugate to study its effects on acute myeloid leukemia
Uses
It is used for the treatment of pancreatic cancer and acute myelogenous leukaemia (AML).
Definition
ChEBI: LSM-1231 is an indolocarbazole.
Biological Activity
Potent JAK2, FLT3 and TrkA inhibitor (IC 50 values are 0.9, 3 and < 25 nM respectively) that prevents STAT5 phosphorylation (IC 50 = 20 - 30 nM). Exhibits antiproliferative activity in vitro (IC 50 = 30 - 100 nM in HEL92.1.7 cells) and is effective against myeloproliferative disorders in vivo .
Biochem/physiol Actions
CEP-701 hydrate, also known as Lestaurtinib, can repress Janus kinase 2/signal transducer and activator of transcription 5 (JAK2/STAT5) signaling by the specific inhibition of JAK2.
storage
-20°C (desiccate)
References
[1] MARK LEVIS Donald S. Novel FLT3 tyrosine kinase inhibitors.[J]. Expert opinion on investigational drugs, 2003, 12 12: 1951-1962. DOI:10.1517/13543784.12.12.1951
[2] PEILI CHEN. FLT3/ITD mutation signaling includes suppression of SHP-1.[J]. The Journal of Biological Chemistry, 2005, 280 7: 5361-5369. DOI:10.1074/jbc.m411974200
[3] CHRISTOPHER J STROCK. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.[J]. Cancer research, 2003: 5559-5563.
[4] ELIZABETH O HEXNER. Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.[J]. Blood, 2008: 5663-5671. DOI:10.1182/blood-2007-04-083402
[5] B A RUGGERI. Role of neurotrophin-trk interactions in oncology: the anti-tumor efficacy of potent and selective trk tyrosine kinase inhibitors in pre-clinical tumor models.[J]. Current medicinal chemistry, 1999, 6 9: 845-857.
Lestaurtinib Preparation Products And Raw materials
Raw materials
Preparation Products
Lestaurtinib Suppliers
- Tel
- 18210857532; 18210857532
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 96815
- Advantage
- 76
- Tel
- 821-50328103-801 18930552037
- Fax
- 86-21-50328109
- 3bsc@sina.com
- Country
- China
- ProdList
- 15838
- Advantage
- 69
- Tel
- 1-(800)-881-8210
- Fax
- 615-250-9817
- inquiries@lgmpharma.com
- Country
- United States
- ProdList
- 2123
- Advantage
- 70
- Tel
- 021-50135380
- shchemsky@sina.com
- Country
- China
- ProdList
- 32321
- Advantage
- 50
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 12952
- Advantage
- 65
- Tel
- 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
- Fax
- +86-27-87599188
- Country
- China
- ProdList
- 1493
- Advantage
- 55
- Tel
- sales@witofly.com
- Country
- China
- ProdList
- 2864
- Advantage
- 52
- Tel
- 021-62960152
- Fax
- 021-52212593
- 934678158@qq.com
- Country
- China
- ProdList
- 9899
- Advantage
- 55
- Tel
- 0531-85828981
- Fax
- +86-531-85806006
- 864598798@qq.com
- Country
- China
- ProdList
- 588
- Advantage
- 58
- Tel
- 18149758185 18149758185;
- sales-cpd@caerulumpharma.com
- Country
- China
- ProdList
- 3505
- Advantage
- 58
View Lastest Price from Lestaurtinib manufacturers
- Product
- Lestaurtinib 111358-88-4
- Price
- US $0.00-0.00/kg
- Min. Order
- 1kg
- Purity
- 99%
- Supply Ability
- 20tons
- Release date
- 2024-12-30
- Product
- Larotrectinib 111358-88-4
- Price
- US $1.30/g
- Min. Order
- 1g
- Purity
- 99%
- Supply Ability
- 500ton/Month
- Release date
- 2021-10-29
- Product
- Lestaurtinib 111358-88-4
- Price
- US $1.10/g
- Min. Order
- 1g
- Purity
- 99.9%
- Supply Ability
- 100 Tons Min
- Release date
- 2021-07-06